Avesthagen signs license agreement with AvestaDHATM
Through the non-elcusive agreement, Avesthagen stands to earn $30 Million over the next decade
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
UKTI Life Sciences delegates to interact with industry leaders from India
Panel discussion to focus on international collaborations in drug delivery science
National Forum on Tuberculosis holds first meeting in New Delhi
Discusses the rise and challenges of drug-resistant TB in India
Scientists from University of Strathclyde invents technology to treat major illnesses
'Shapeshifting' computer programme will open up drug discovery for tricky disease targets
Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis
OPPI holds seminar on challenges and future roadmap for healthcare access in India
Top policy makers and healthcare stakeholders offer rich insights for achieving efficient and affordable healthcare access for all…
Competition intensifies as pharma companies race to launch type II diabetes drugs
New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time
Indian pharma market posts growth of 13.5 per cent: IMS Health
The market has kicked off second half of the year emphatically with the growth rebounding strongly after a rather subdued first…
MCVR receives $1.143 million grant from Centers for Disease Control and Prevention
The grant was awarded for the application submitted by Dr G Arunkumar and Dr TMA Pai, for detecting etiologies of emerging…
World’s pharma development manufacturing base moving to India: IBEF
Generics exports growth of nearly 30 per cent enabling greater research spend
West-Coast Pharmaceutical Works to foray into nutraceutical segment
Initially to launch the products in the western region of the country
SIES College of Arts, Science & Commerce to organise workshop on Bioanalysis: Sample…
Workshop to be held on September 7, 2013
DPCO’13 impacts July growth
But growth back to double digits for products still out of price control
Quintiles to acquire Novella Clinical
Acquisition bolsters Quintiles’ small biopharma, oncology and medical device capabilities
US FDA approves new drug to treat HIV infection
However, MSF warns manufacturer's pricing strategy will keep it out of reach in developing countries excluded from licensing deals…
Pall Corporation opens expanded SLS Technical Support Centre in Bangalore
To further enhances Pall’s capability to support the process development needs of its customers across various industries
VICAM launches mobile app for instant access to global mycotoxin regulations
Product now available for download on Google Play, iTunes Store or www.commodityregs.com